These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 9384610)

  • 1. In vitro reactivation of the FMR1 gene involved in fragile X syndrome.
    Chiurazzi P; Pomponi MG; Willemsen R; Oostra BA; Neri G
    Hum Mol Genet; 1998 Jan; 7(1):109-13. PubMed ID: 9384610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of DNA demethylation and transcriptional reactivation of the FMR1 gene in fragile X cells treated with 5-azadeoxycytidine.
    Pietrobono R; Pomponi MG; Tabolacci E; Oostra B; Chiurazzi P; Neri G
    Nucleic Acids Res; 2002 Jul; 30(14):3278-85. PubMed ID: 12136110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effect of histone hyperacetylation and DNA demethylation in the reactivation of the FMR1 gene.
    Chiurazzi P; Pomponi MG; Pietrobono R; Bakker CE; Neri G; Oostra BA
    Hum Mol Genet; 1999 Nov; 8(12):2317-23. PubMed ID: 10545613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation mosaicism of 5'-(CGG)(n)-3' repeats in fragile X, premutation and normal individuals.
    Genç B; Müller-Hartmann H; Zeschnigk M; Deissler H; Schmitz B; Majewski F; von Gontard A; Doerfler W
    Nucleic Acids Res; 2000 May; 28(10):2141-52. PubMed ID: 10773084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcription of the FMR1 gene in individuals with fragile X syndrome.
    Tassone F; Hagerman RJ; Chamberlain WD; Hagerman PJ
    Am J Med Genet; 2000; 97(3):195-203. PubMed ID: 11449488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation analysis of CGG sites in the CpG island of the human FMR1 gene.
    Hansen RS; Gartler SM; Scott CR; Chen SH; Laird CD
    Hum Mol Genet; 1992 Nov; 1(8):571-8. PubMed ID: 1301165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential epigenetic modifications in the FMR1 gene of the fragile X syndrome after reactivating pharmacological treatments.
    Tabolacci E; Pietrobono R; Moscato U; Oostra BA; Chiurazzi P; Neri G
    Eur J Hum Genet; 2005 May; 13(5):641-8. PubMed ID: 15741991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A deletion of 1.6 kb proximal to the CGG repeat of the FMR1 gene causes the clinical phenotype of the fragile X syndrome.
    Meijer H; de Graaff E; Merckx DM; Jongbloed RJ; de Die-Smulders CE; Engelen JJ; Fryns JP; Curfs PM; Oostra BA
    Hum Mol Genet; 1994 Apr; 3(4):615-20. PubMed ID: 8069307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mosaicism for the fragile X syndrome full mutation and deletions within the CGG repeat of the FMR1 gene.
    Milà M; Castellví-Bel S; Sánchez A; Lázaro C; Villa M; Estivill X
    J Med Genet; 1996 Apr; 33(4):338-40. PubMed ID: 8730293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Normal phenotype in two brothers with a full FMR1 mutation.
    Smeets HJ; Smits AP; Verheij CE; Theelen JP; Willemsen R; van de Burgt I; Hoogeveen AT; Oosterwijk JC; Oostra BA
    Hum Mol Genet; 1995 Nov; 4(11):2103-8. PubMed ID: 8589687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase of FMRP expression, raised levels of FMR1 mRNA, and clonal selection in proliferating cells with unmethylated fragile X repeat expansions: a clue to the sex bias in the transmission of full mutations?
    Salat U; Bardoni B; Wöhrle D; Steinbach P
    J Med Genet; 2000 Nov; 37(11):842-50. PubMed ID: 11073538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypomethylation of an expanded FMR1 allele is not associated with a global DNA methylation defect.
    Burman RW; Yates PA; Green LD; Jacky PB; Turker MS; Popovich BW
    Am J Hum Genet; 1999 Nov; 65(5):1375-86. PubMed ID: 10521303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rare variants in the promoter of the fragile X syndrome gene (FMR1).
    Milà M; Castellví-Bel S; Sánchez A; Barceló A; Badenas C; Mallolas J; Estivill X
    Mol Cell Probes; 2000 Apr; 14(2):115-9. PubMed ID: 10799273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic variation illustrated by DNA methylation patterns of the fragile-X gene FMR1.
    Stöger R; Kajimura TM; Brown WT; Laird CD
    Hum Mol Genet; 1997 Oct; 6(11):1791-801. PubMed ID: 9302255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the FMR1 gene.
    Tassone F; Hagerman PJ
    Cytogenet Genome Res; 2003; 100(1-4):124-8. PubMed ID: 14526172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of the FMR1 gene mutation to human intellectual dysfunction.
    Reiss AL; Freund LS; Baumgardner TL; Abrams MT; Denckla MB
    Nat Genet; 1995 Nov; 11(3):331-4. PubMed ID: 7581460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular predictors of cognitive involvement in female carriers of fragile X syndrome.
    Taylor AK; Safanda JF; Fall MZ; Quince C; Lang KA; Hull CE; Carpenter I; Staley LW; Hagerman RJ
    JAMA; 1994 Feb; 271(7):507-14. PubMed ID: 8301764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fragile X males with unmethylated, full mutation trinucleotide repeat expansions have elevated levels of FMR1 messenger RNA.
    Tassone F; Hagerman RJ; Loesch DZ; Lachiewicz A; Taylor AK; Hagerman PJ
    Am J Med Genet; 2000 Sep; 94(3):232-6. PubMed ID: 10995510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of all CGG repeats plus flanking sequences in FMR1 does not abolish gene expression.
    Grønskov K; Hjalgrim H; Bjerager MO; Brøndum-Nielsen K
    Am J Hum Genet; 1997 Oct; 61(4):961-7. PubMed ID: 9382110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of FMR1 hypermethylation in somatic cell heterokaryons.
    Stoyanova V; Rossetti S; VAN Unen L; Oostra BA; Hoogeveen AT
    FASEB J; 2004 Dec; 18(15):1964-6. PubMed ID: 15377638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.